Abstract | AIMS: Although the expression of oligodendrocyte-related genes in post-mortem brains of patients with schizophrenia is consistently reported to be downregulated, the cause of the change remains unclear. The A-allele of rs2070106 within the 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP), an oligodendrocyte-related gene, was reported to show reduced expression compared with the G-allele, and proposed to be associated with schizophrenia. METHODS: The effect of the rs2070106 genotype on the expression of CNP and other oligodendrocyte-related genes was examined using data previously obtained from DNA microarray studies of post-mortem brains. RESULTS: It was found that the effect of rs2070106 genotype on the CNP expression was transcript specific, and that the genotype was not associated with the expression of other oligodendrocyte-related genes. CONCLUSIONS: The rs207016 genotype is not likely to contribute to the reported coordinated down-regulation of oligodendrococyte-related genes in schizophrenia.
|
Authors | Kazuya Iwamoto, Junko Ueda, Miki Bundo, Yoko Nakano, Tadafumi Kato |
Journal | Psychiatry and clinical neurosciences
(Psychiatry Clin Neurosci)
Vol. 62
Issue 1
Pg. 103-8
(Feb 2008)
ISSN: 1440-1819 [Electronic] Australia |
PMID | 18289148
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Myelin Proteins
- 2',3'-Cyclic-Nucleotide Phosphodiesterases
|
Topics |
- 2',3'-Cyclic-Nucleotide Phosphodiesterases
(genetics)
- Bipolar Disorder
(diagnosis, genetics, pathology)
- Depressive Disorder, Major
(diagnosis, genetics, pathology)
- Down-Regulation
(genetics)
- Gene Expression
(genetics)
- Gene Expression Profiling
- Genotype
- Humans
- Myelin Proteins
(genetics)
- Oligodendroglia
(metabolism, pathology)
- Oligonucleotide Array Sequence Analysis
- Polymorphism, Single Nucleotide
(genetics)
- Prefrontal Cortex
(pathology)
- Schizophrenia
(diagnosis, genetics, pathology)
|